Activation of Biobank Registry for Bilio-pancreatic Diseases
Launched by IRCCS SAN RAFFAELE · Aug 12, 2024
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding the causes of certain pancreatic diseases, including pancreatitis and pancreatic cancer. Researchers are creating a biobank, which is a collection of biological samples and health information from participants. This biobank will help them study how both genetics (inherited traits) and environmental factors (like lifestyle or exposure to certain substances) may work together to influence the development of these diseases. By identifying different risk factors, they hope to improve prevention and early diagnosis of these conditions.
To participate in this trial, individuals must be at least 18 years old and willing to provide informed consent, which means they agree to take part in the study after understanding what it involves. The trial is open to all genders, and it is currently recruiting participants. Those who join can expect to provide samples and health information that will contribute to important research that could lead to better understanding and treatment of pancreatic diseases.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • age \>= 18 years
- • signed informed consent
- Exclusion Criteria:
- • age \< 18 years
- • unwilling to sign informed consent
About Irccs San Raffaele
IRCCS San Raffaele is a prestigious research hospital and clinical trial sponsor based in Milan, Italy, renowned for its commitment to advancing medical science through innovative research and high-quality patient care. As an Institute for Research and Healthcare, it specializes in a wide range of therapeutic areas, including oncology, neurology, and cardiology, and is dedicated to translating scientific discoveries into effective clinical practices. With a multidisciplinary team of experts and state-of-the-art facilities, IRCCS San Raffaele plays a pivotal role in conducting rigorous clinical trials that contribute to the development of novel treatments and improve patient outcomes globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Milano, , Italy
Patients applied
Trial Officials
Paolo Giorgio Arcidiacono, MD
Principal Investigator
IRCCS Ospedale San Raffaele
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported